Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, non-apoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated

Bruno Ségui

Delphine Milhas

Elodie Lafont

Frederic Rieux-Laucat

Hervé Benoist

Justin Teissié

Nathalie Andrieu-Abadie

Nicole Therville

Thierry Levade

English

PubMed

Crossref

PLoS ONE

Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk

BACKGROUND: Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, non-apoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated. METHODOLOGY AND PRINCIPAL FINDINGS: The present study shows that FasL-induced cell death was completely impaired in caspase-8- and caspase-10-doubly deficient (I9-2e) Jurkat leukaemia T-cell lines. Over-expressing of either caspase-8 or caspase-10 in I9-2e cells triggered cell death and restored sensitivity to FasL, further arguing for a role of both initiator caspases in Fas apoptotic signalling. In the presence of zVAD-fmk, FasL triggered an alternative form of cell death similarly in wild-type (A3) and in caspase-8-deficient Jurkat cells expressing endogenous caspase-10 (clone I9-2d). Cell death initiated by Fas stimulation in the presence of zVAD-fmk was abrogated in I9-2e cells as well as in HeLa cells, which did not express endogenous caspase-10, indicating that caspase-10 somewhat participates in this alternative form of cell death. Noteworthy, ectopic expression of caspase-10 in I9-2e and HeLa cells restored the ability of FasL to trigger cell death in the presence of zVAD-fmk. As a matter of fact, FasL-triggered caspase-10 processing still occurred in the presence of zVAD-fmk. CONCLUSIONS AND SIGNIFICANCE: Altogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling

Directory of Open Access Journals

Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk.

International audienceAltogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling

Lafont, Elodie

Milhas, Delphine

Teissié, Justin

Therville, Nicole

Andrieu-Abadie, Nathalie

Levade, Thierry

Benoist, Hervé

Ségui, Bruno

HAL-Inserm

Lafont, E

Milhas, D

Teissié, J

Therville, N

Andrieu-Abadie, N

Levade, T

Benoist, H

Ségui, B

UCL Discovery

Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk

Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, non-apoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated.The present study shows that FasL-induced cell death was completely impaired in caspase-8- and caspase-10-doubly deficient (I9-2e) Jurkat leukaemia T-cell lines. Over-expressing of either caspase-8 or caspase-10 in I9-2e cells triggered cell death and restored sensitivity to FasL, further arguing for a role of both initiator caspases in Fas apoptotic signalling. In the presence of zVAD-fmk, FasL triggered an alternative form of cell death similarly in wild-type (A3) and in caspase-8-deficient Jurkat cells expressing endogenous caspase-10 (clone I9-2d). Cell death initiated by Fas stimulation in the presence of zVAD-fmk was abrogated in I9-2e cells as well as in HeLa cells, which did not express endogenous caspase-10, indicating that caspase-10 somewhat participates in this alternative form of cell death. Noteworthy, ectopic expression of caspase-10 in I9-2e and HeLa cells restored the ability of FasL to trigger cell death in the presence of zVAD-fmk. As a matter of fact, FasL-triggered caspase-10 processing still occurred in the presence of zVAD-fmk.Altogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling

Lafont Elodie

Milhas Delphine

Teissié Justin

Therville Nicole

Andrieu-Abadie Nathalie

Levade Thierry

Benoist Hervé

Ségui Bruno

Public Library of Science (PLOS)

An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.

Apoptotic and necrotic cell death induced by death domain receptors.

Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

Caspase involvement in RIPassociated CD95-induced T cell apoptosis.

Caspase-10 is an initiator caspase in death receptor signaling.

Caspase-10 is recruited to and activated at the native TRAIL and CD95 deathinducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases.

Caspase-8 mediates mitochondrial release of pro-apoptotic proteins in a manner independent of its proteolytic activity in apoptosis induced by the protein synthesis inhibitor acetoxycycloheximide in human leukemia Jurkat cells.

Caspase-independent cell killing by Fas-associated protein with death domain.

Caspase10 triggers bid cleavage and caspase cascade activation in FasL-induced apoptosis.

Caspases: the executioners of apoptosis.

Causes and consequences of the autoimmune lymphoproliferative syndrome.

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

Cloning and characterization of a novel caspase-10 isoform that activates NF-kappaB activity.

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.

Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis.

Essential requirement for caspase-8/ FLICE in the initiation of the Fas-induced apoptotic cascade.

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Fas-associated death domain protein interleukin1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling.

FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens.

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex.

Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.

In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.

Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.

Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells.

Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system.

Necrotic death pathway in Fas receptor signaling.

Non-apoptotic functions of caspase-8.

Retroactive pathway involving mitochondria in electroloaded cytochrome c-induced apoptosis.

Structure/Function analysis of p55 tumor necrosis factor receptor and fasassociated death domain. Effect on necrosis in L929sA cells.

Thorburn A

Unique and overlapping substrate specificities of caspase-8 and caspase-10.

Caspase-10-Dependent Cell Death in Fas/CD95 Signalling Is Not Abrogated by Caspase Inhibitor zVAD-fmk

Abstract

Similar works

Full text

Available Versions

Crossref

Directory of Open Access Journals

HAL-Inserm

UCL Discovery

Public Library of Science (PLOS)